Article Details
Retrieved on: 2018-02-16 21:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors increased Sarepta Therapeutics I Com (SRPT) stake by 104% reported in 2017Q3 SEC filing. <b>Benchmark Capital</b> Advisors acquired 10,400 shares as Sarepta Therapeutics I Com (SRPT)'s stock rose 22.49%. The <b>Benchmark Capital</b> Advisors holds 20,400 shares with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here